Human SENP1 activation kit by CRISPRa

CAT#: GA109280

SENP1 CRISPRa kit - CRISPR gene activation of human SUMO specific peptidase 1



  See Other Versions

CNY 12,255.00


货期*
4周

规格
    • 1 kit

Product images

经常一起买 (3)
SENP1 mouse monoclonal antibody, clone OTI1D7 (formerly 1D7)
    • 100 ul

CNY 1,999.00
CNY 2,700.00


SENP1 (Myc-DDK tagged) - Homo sapiens SUMO1/sentrin specific peptidase 1 (SENP1), transcript variant 2
    • 10 ug

CNY 6,460.00


SENP1 mouse monoclonal antibody, clone OTI1D7 (formerly 1D7)
    • 30 ul

CNY 800.00

Specifications

Product Data
Format 3 gRNAs (5ug each), 1 scramble ctrl (10ug) and 1 enhancer vector (10ug)
Symbol SENP1
Locus ID 29843
Kit Components

GA109280G1, SENP1 gRNA vector 1 in pCas-Guide-GFP-CRISPRa

GA109280G2, SENP1 gRNA vector 2 in pCas-Guide-GFP-CRISPRa

GA109280G3, SENP1 gRNA vector 3 in pCas-Guide-GFP-CRISPRa

1 CRISPRa-Enhancer vector, SKU GE100056

1 CRISPRa scramble vector, SKU GE100077

Disclaimer These products are manufactured and supplied by OriGene under license from ERS. The kit is designed based on the best knowledge of CRISPRa SAM technology. The efficiency of the activation can be affected by many factors, including nucleosome occupancy status, chromatin structure and the gene expression level of the target, etc.
Reference Data
RefSeq NM_001267594, NM_001267595, NM_014554, NR_051991, NR_051992
Synonyms SuPr-2
Summary This gene encodes a cysteine protease that specifically targets members of the small ubiquitin-like modifier (SUMO) protein family. This protease regulates SUMO pathways by deconjugating sumoylated proteins. This protease also functions to process the precursor SUMO proteins into their mature form. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Jun 2012]
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.

Documents

Other Versions

Customer Reviews 
Loading...